The present invention provides methods for treating hyperlipidemia in patients who are not on statin therapy. The methods of the present invention comprise administering to a patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody such as the exemplary antibody referred to herein as mAb316P.
申请公布号
WO2015054619(A2)
申请公布日期
2015.04.16
申请号
WO2014US60109
申请日期
2014.10.10
申请人
SANOFI;REGENERON PHARMACEUTICALS, INC.
发明人
BACCARA-DINET, MARIE;BESSAC, LAURENCE;CHAUDHARI, UMESH;HANOTIN, CORINNE;PORDY, ROBERT, C.;SASIELA, WILLIAM, J.;GIPE, DANIEL A., SCHWEMMER
